Purvis v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided August 21, 2017·No. 14-1025·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 14-1025V July 25, 2017 Not to be Published

*************************************** CHRISTOPHER PURVIS, * * Petitioner, * Not to be Published * v. * Influenza (“flu”) vaccine; * diskitis; testicular pain; SECRETARY OF HEALTH * not immune-mediated; AND HUMAN SERVICES, * not autoimmune; dismissal * Respondent. * *************************************** Howard S. Gold, Wellesley Hills, MA, for petitioner. Ryan D. Pyles, Washington, DC, for respondent.

MILLMAN, Special Master

DECISION 1

On October 22, 2014, petitioner filed a petition under the National Childhood Vaccine Injury Act, 42 U.S.C. §§ 300aa-10–34 (2006), alleging that the influenza (“flu”) vaccine he received on August 15, 2013, caused burning pain in his back, abdomen, and testicles. Pet. ¶ 4.

On July 7, 2017, the undersigned held a hearing. Testifying for petitioner was Dr. David Axelrod, an immunologist and allergist. Testifying for respondent was Dr. Kathleen L. Collins, an infectious disease specialist.

1 Because this unpublished decision contains a reasoned explanation for the special master’s action in this case, the special master intends to post this unpublished decision on the United States Court of Federal Claims’ website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). Vaccine Rule 18(b) states that all decisions of the special masters will be made available to the public unless they contain trade secrets or commercial or financial information that is privileged and confidential, or medical or similar information whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a decision is filed, petitioner has 14 days to identify and move to redact such information prior to the document’s disclosure. If the special master, upon review, agrees that the identified material fits within the banned categories listed above, the special master shall redact such material from public access. Dr. Axelrod’s explanation for flu vaccine causing petitioner’s diskitis was based on his assumption that diskitis was an autoimmune disease because petitioner was ill, and that cytokines from flu vaccine caused increased vascularization and nerve sensitivity. Dr. Collins’ response was that spinal discs do not contain blood vessels or nerves and, therefore, whether or not cytokines could breach the blood-brain barrier would be irrelevant to inflammation of his spinal discs. Because the undersigned found Dr. Collins’ testimony more credible than Dr. Axelrod’s, the undersigned DISMISSES this case.

FACTS

Petitioner was born on October 12, 1959. Med. recs. Ex. 1, at 1.

Pre-vaccination records

Petitioner gave a history in numerous medical records that a car hit him when he was a pedestrian in 2009, and he has had back problems since then. Med. recs. Ex. 5, at 313. He has been disabled since 2000. Id.

On August 9, 2010, petitioner was at Lawrence & Memorial Hospital, complaining that he flew over his motorcycle handlebars and landed on his right hip. Id. at 18. He complained of pain in his right arm and shoulder, although the shoulder pain was chronic. Id.

On August 12, 2010, petitioner saw Dr. Robert J. Keitner, Jr., in follow-up. Med. recs. Ex. 4, at 2. Petitioner had a history of asthma, hypertension, hyperlipidemia, seizure disorder, migraine headaches, depression, chronic pain, and probable post-traumatic injury. Id. Earlier that year, he had acute renal insufficiency, probably related to excessive use of diuretics and NSAIDs and inadequate fluid intake. Id. At the time of his visit, petitioner was taking

2 Lamictal, 2 Klonopin, 3 Geodon, 4 Lexapro, 5 Ambien, 6 Zetia, 7 Clonidine,8 Trilipix, 9 and Percocet. 10 Id. He also used Levitra for erectile dysfunction as needed. Id. He weighed 250 pounds. Id.

On November 16, 2010, petitioner saw Dr. Keitner. Id. at 8. Petitioner had a history of previous drug abuse and was on methadone 11 maintenance. Id. He had a history of hepatitis C and cirrhosis. Id.

On February 24, 2011, petitioner saw Dr. Keitner again. Id. at 11. For the last two or

2 Lamictal is “trademark for a preparation of lamotrigine.” Dorland’s Illustrated Medical Dictionary 1000 (32d ed. 2012) (hereinafter, “Dorland’s). Lamotrigine is “an anticonvulsant used in the treatment of partial seizures in adult patients . . . .” Id. at 1003. 3 Klonopin is “trademark for a preparation of clonazepam.” Dorland’s at 989. Clonazepam is “a benzodiazepine used as an anticonvulsant in the treatment of Lennox-Gastaut syndrome and of atonic and myoclonic seizures and as an antipanic agent in the treatment of panic disorders . . . .” Id. at 373. Benzodiazepine is “any of a group of compounds having a common molecular structure and acting similarly as depressants of the central nervous system, their actions including antianxiety, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxing effects.” Id. at 209. 4 Geodon is “trademark for a preparation of ziprasidone hydrochloride.” Dorland’s at 772. Ziprasidone hydrochloride is “an antipsychotic used in the treatment of schizophrenia.” Id. at 2092. 5 Lexapro is “trademark for a preparation of escitalopram oxalate.” Dorland’s at 1032. Escitalopram oxalate is “a selective serotonin reuptake inhibitor (SSRI) . . .; used as an antidepressant.” Id. at 647. 6 Ambien is “trademark for a preparation of zolpidem tartrate.” Dorland’s at 57. Zolpidem tartrate is “a non-benzodiazepine sedative-hypnotic . . . in the short-term treatment of insomnia.” Id. at 2092. 7 Zetia is “trademark for a preparation of ezetimibe.” Dorland’s at 2091. Ezetimibe is “an inhibitor of intestinal cholesterol absorption . . . in the treatment of primary hypercholesterolemia.” Id. at 667. 8 Clonidine hydrochloride is “DQ ‫ܤ‬2-adrenergic agonist-antagonist . . .administered . . .as an antihypertensive. . . .” Dorland’s at 373. 9 Trilipix is “trademark for a preparation of fenofibric acid.” Dorland’s at 1967. Fenofibric acid is “the active form of fenofibrate, used in combination with statins to reduce elevated serum lipids.” Id. at 688. 10 Percocet is “trademark for a combination preparation of oxycodone hydrochloride and acetaminophen.” Dorland’s at 1409. Oxycodone is “an opioid agonist analgesic derived from morphine.” Id. at 1356. 11 Methadone hydrochloride is “a synthetic opioid analgesic, possessing pharmacologic actions similar to those of morphine and heroin and similar potential for addiction; used as an analgesic and as a narcotic abstinence syndrome suppressant in the treatment of heroin addiction . . . .” Dorland’s at 1146. 3 three weeks, petitioner had noted significantly increasing chest tightness or wheezing and cough. Id. He said he was smoking three or four cigarettes a day, but did not usually finish them. Id.

On May 9, 2011, petitioner went to Lawrence & Memorial Hospital Emergency Department after he fell in the shower, complaining of back pain that had lasted one month. Med. recs. Ex. 5, at 64.

On May 16, 2011, petitioner saw his orthopedist, Dr. Frank W. Maletz, because he had a very nasty fall in the shower. Med. recs. Ex. 7, at 1. He slipped and fell backwards as his right knee gave out. Id. He struck his lower back, twisted, hit his head on the side of the bathtub, and injured his upper back as well. Id. Dr. Maletz wrote that petitioner was struggling significantly with his lower back and had greater difficulty with his right knee. Id. Petitioner had Lidoderm 12 patches all over his lower lumbar spine and over the mid-shaft of his tibia. Id. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Purvis v. Secretary of Health and Human Services, (uscfc 2017).

Purvis v. Secretary of Health and Human Services (Purvis v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related